Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
Craig TJ
,
Shimomura K
,
Holl RW
,
Flanagan SE
,
Ellard S
,
Ashcroft FM
.
???displayArticle.abstract???
CONTEXT: Activating mutations in genes encoding the Kir6.2 (KCNJ11) and SUR1 (ABCC8) subunits of the pancreatic ATP-sensitive K(+) channel are a common cause of permanent neonatal diabetes (PNDM). All Kir6.2 mutations identified to date are missense mutations. We describe here a novel in-frame deletion (residues 28-32) in Kir6.2 in a heterozygous patient with PNDM without neurological problems that are detectable by standard evaluation.
OBJECTIVE: The aim of the study was to identify the mutation responsible for neonatal diabetes in this patient and characterize its functional effects.
DESIGN: Wild-type and mutant Kir6.2/SUR1 channels were examined by heterologous expression in Xenopus oocytes.
RESULTS: The Kir6.2-28Delta32 mutation produced a significant decrease in ATP inhibition and an increase in whole-cell K(ATP) currents, explaining the diabetes of the patient. Tolbutamide block was only slightly reduced in the simulated heterozygous state, suggesting that the patient should respond to sulfonylurea therapy. The mutation decreased ATP inhibition indirectly, by increasing the intrinsic (unliganded) channel open probability. Neither effect was observed when Kir6.2 was expressed in the absence of SUR1, suggesting that the mutation impairs coupling between SUR1 and Kir6.2. Coimmunoprecipitation studies further revealed that the mutation disrupted a physical interaction between Kir6.2 and residues 1-288 (but not residues 1-196) of SUR1.
CONCLUSIONS: We report a novel KCNJ11 mutation causing PNDM. Our results show that residues 28-32 in the N terminus of Kir6.2 interact both physically and functionally with SUR1 and suggest that residues 196-288 of SUR1 are important in this interaction.
Ashcroft,
The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady.
2007, Pubmed
Ashcroft,
The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady.
2007,
Pubmed
Ashcroft,
ATP-sensitive potassium channelopathies: focus on insulin secretion.
2005,
Pubmed
Ashcroft,
K(ATP) channels and insulin secretion: a key role in health and disease.
2006,
Pubmed
Babenko,
Sur domains that associate with and gate KATP pores define a novel gatekeeper.
2003,
Pubmed
Babenko,
The N-terminus of KIR6.2 limits spontaneous bursting and modulates the ATP-inhibition of KATP channels.
1999,
Pubmed
Babenko,
SUR-dependent modulation of KATP channels by an N-terminal KIR6.2 peptide. Defining intersubunit gating interactions.
2002,
Pubmed
Babenko,
Two regions of sulfonylurea receptor specify the spontaneous bursting and ATP inhibition of KATP channel isoforms.
1999,
Pubmed
Chan,
N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits.
2003,
Pubmed
,
Xenbase
Flanagan,
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.
2006,
Pubmed
Girard,
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
2006,
Pubmed
,
Xenbase
Gloyn,
Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
2006,
Pubmed
Gloyn,
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
2004,
Pubmed
,
Xenbase
Gribble,
Sulphonylurea action revisited: the post-cloning era.
2003,
Pubmed
Gribble,
Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Gribble,
Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA.
1998,
Pubmed
,
Xenbase
Hattersley,
Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.
2005,
Pubmed
Koster,
Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes.
2000,
Pubmed
Mikhailov,
3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1.
2005,
Pubmed
Nichols,
KATP channels as molecular sensors of cellular metabolism.
2006,
Pubmed
Nichols,
Adenosine diphosphate as an intracellular regulator of insulin secretion.
1996,
Pubmed
Pearson,
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
2006,
Pubmed
,
Xenbase
Proks,
Phentolamine block of KATP channels is mediated by Kir6.2.
1997,
Pubmed
,
Xenbase
Proks,
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
2004,
Pubmed
,
Xenbase
Proks,
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
2006,
Pubmed
,
Xenbase
Proks,
Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.
2007,
Pubmed
,
Xenbase
Proks,
Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
2006,
Pubmed
,
Xenbase
Proks,
A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.
2005,
Pubmed
,
Xenbase
Reimann,
Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
1999,
Pubmed
,
Xenbase
Shyng,
Octameric stoichiometry of the KATP channel complex.
1997,
Pubmed
Shyng,
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
1997,
Pubmed
Tammaro,
Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
2006,
Pubmed
,
Xenbase
Tammaro,
Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
2005,
Pubmed
,
Xenbase
Tucker,
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
1997,
Pubmed
,
Xenbase
Zerangue,
A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels.
1999,
Pubmed
,
Xenbase
